CD38 and tuberculosis: Moreover, Ahmed et al. showed that At nine weeks of anti- TB treatment, the frequency of T cell activation and proliferation markers (CD38, HLA-DR, Ki67) were significantly reduced (p< 0.0001) whereas the frequency of CD4+ T was not changed.